Prostate Cancer Therapeutics

World Market Report

MCP-1747

EXECUTIVE ENGAGEMENTS

POOL

8132
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1138
Interactions with Platform & by Email

PARTICIPANTS

244
Unique # Participated

VALIDATIONS

86
Responses Validated*

COMPANIES

76
Responses Validated*
* Login for a full stack data experience

DATE

OCT 2022

TABLES

122

PAGES

212

EDITION

15

PRICE

USD 5600

CODE

MCP-1747


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

STRONG ACTIVE NICHE TRIVIAL

%

VALIDATED RESEARCH *

S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Amid the COVID-19 crisis, the global market for Prostate Cancer Therapeutics estimated at US$12.3 Billion in the year 2020, is projected to reach a revised size of US$19.1 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Hormone Therapy, one of the segments analyzed in the report, is projected to record a 6.7% CAGR and reach US$15.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Targeted Therapy segment is readjusted to a revised 5.8% CAGR for the next 7-year period.
The Prostate Cancer Therapeutics market in the U.S. is estimated at US$3.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2027 trailing a CAGR of 6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6% and 5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.
In the global Chemotherapy segment, USA, Canada, Japan, China and Europe will drive the 5.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$659.3 Million in the year 2020 will reach a projected size of US$960.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.2 Billion by the year 2027.

SELECT PLAYERS

AbbVie Inc.; Allergan plc; Amgen Inc.; Astellas Pharma Inc.; AstraZeneca Plc.; Bayer AG; Bristol-Myers Squibb Company; Debiopharm Group; Endo Pharmaceuticals Inc.; F. Hoffmann-La Roche Ltd.; Genentech Inc.; GlaxoSmithKline Plc; Janssen Biotech Inc.; Novartis AG; Pfizer Inc.; Progenics Pharmaceuticals Inc.; Sanofi S.A.; Spectrum Pharmaceuticals Inc.; Takeda Pharmaceutical Company Limited; TOLMAR Pharmaceuticals Inc.

SEGMENTS

» Therapy Type (Hormone Therapy, Targeted Therapy, Chemotherapy, Targeted Therapy) » Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online sales, Other Distribution Channels)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Recent Market Activity
An Insight in the Global Market for Prostate Cancer Diagnostics and Therapeutics
Rising Incidence of Prostate Cancer: Cornerstone for the Market
Current & Future Analysis
Developing Countries Turbo Charge Future Market Growth
An Insight into the Castration-Resistant Prostate Cancer Therapeutics Market
Hormone Therapies to Dominate Global Prostate Cancer Therapeutics Market
Key Prostate Cancer Hormone Therapy Drugs & Companies: 2017
Targeted Therapy - The New Frontier of Cancer Treatment
Radiotherapy - Gaining Prominence
Metastatic Prostate Cancer - Apt for Precision Oncology
Launch of Generic Drugs to Place Established Players in Jeopardy
Demographics & Lifestyles Raise the Risk of Prostate Cancer
Select General Risk Factors and their Relative Risk Rate in Prostate Cancer
Small Cap Companies: A Target of Private Capital Financing
Cost Analysis of Currently Available Treatment
Growth Drivers
Growth Restraints
Pipeline of Drugs in Clinical Trials
Innovations & Advancements
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Prostate Cancer Therapeutics – Global Key Competitors Percentage Market Share in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Prostate Cancer Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Prostate Cancer Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Hormone Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Hormone Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hormone Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Targeted Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Online Sales by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Online Sales by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Online Sales by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Prostate Cancer Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
UNITED STATES
Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027
JAPAN
Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027
CHINA
Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027
EUROPE
Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Prostate Cancer Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Prostate Cancer Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027
FRANCE
Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027
GERMANY
Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027
UNITED KINGDOM
Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Prostate Cancer Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Prostate Cancer Therapeutics by Therapy Type - Hormone Therapy, Targeted Therapy and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Prostate Cancer Therapeutics by Therapy Type - Percentage Breakdown of Value Sales for Hormone Therapy, Targeted Therapy and Chemotherapy for the Years 2012, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Prostate Cancer Therapeutics by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Prostate Cancer Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Sales and Other Distribution Channels for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com